Bisphosphonate drugs compared
Compare all 8 Bisphosphonate drugs side by side, used for conditions such as hypercalcemia, osteolysis, paget disease, extramammary. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is aredia.
Top-rated bisphosphonate: 1. Aredia · 2. Zometa · 3. Reclast
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Aredia | Pamidronate Disodium | Injectable | Prescription | Hypercalcemia, Osteolysis | 70/100 | — |
| Zometa | Zoledronic Acid | Injectable | Prescription | Bone Neoplasms, Hypercalcemia | 70/100 | $0 |
| Reclast | Zoledronic Acid | Injectable | Prescription | Bone Neoplasms, Hypercalcemia | 68/100 | $0 |
| Risedronate Sodium | — | Tablet | Prescription | Paget Disease, Extramammary, Osteoporosis, Postmenopausal | 56/100 | $73 |
| Actonel | Risedronate Sodium | Tablet | Prescription | Paget Disease, Extramammary, Osteoporosis, Postmenopausal | Not yet rated | $73 |
| Atelvia | Risedronate Sodium | Tablet | Prescription | Paget Disease, Extramammary, Osteoporosis, Postmenopausal | Not yet rated | $73 |
| Binosto | Alendronate Sodium | Tablet | Prescription | Paget Disease, Extramammary, Osteoporosis, Postmenopausal | Not yet rated | $8 |
| Zoledronic Acid | — | Injectable | Prescription | Bone Neoplasms, Hypercalcemia | Not yet rated | $0 |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best bisphosphonate by condition
Full ranking · 8 drugs
- 170/100
aredia
Pamidronate Disodium
- 270/100
zometa
Zoledronic Acid
- 368/100
reclast
Zoledronic Acid
- 456/100
risedronate sodium
Risedronate Sodium
- 5New
actonel
Risedronate Sodium
- 6New
atelvia
Risedronate Sodium
- 7New
binosto
Alendronate Sodium
- 8New
zoledronic acid
Zoledronic Acid
Frequently asked questions
What is the Bisphosphonate drug class?
Bisphosphonate is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 8 Bisphosphonate products, each independently rated.
Are all Bisphosphonate drugs the same?
No. Bisphosphonate drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Bisphosphonate drugs treat?
Per NIH RxClass drug-classification data, Bisphosphonate drugs are used for conditions including hypercalcemia, osteolysis, paget disease, extramammary, osteoporosis, postmenopausal, bone neoplasms, multiple myeloma.
Which Bisphosphonate drug is best-rated?
By our independent rating, aredia currently ranks highest among Bisphosphonate drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Bisphosphonate class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Bisphosphonate - StatPearls - NCBI Bookshelf. Ratings are pharmaranks’ independent FDA recall-safety analysis.